Latest Statin Stories
Analysis From Prespecified Exploratory Endpoints Presented in Late-Breaking Session at ACC.15 Showed Repatha Plus Standard of Care Lowered Cardiovascular Events THOUSAND OAKS, Calif., March
Robust and consistent LDL-C lowering demonstrated with Praluent(TM) in largest, double-blind, placebo-controlled trial of a PCSK9 inhibitor to date TARRYTOWN, N.Y.
Data From PCSK9 Inhibitor Study Support Regulatory Filing in Japan THOUSAND OAKS, Calif., March 14, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced new detailed data from the Phase
Data Evaluating the Effect of Repatha(TM)(Evolocumab) on LDL-C and Cardiovascular Events to be Featured in Late-Breaking Session THOUSAND OAKS, Calif., March 2, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN)
In a nested-case control study of individuals living in the UK, a part of the world with a relatively low incidence of liver cancer, statin use is associated with a decreased risk of liver cancer,
The Firm is representing numerous Lipitor lawsuit plaintiffs in the federal litigation, and bellwether trials may provide insight into jury decisions in similar claims involving allegations that
Congressional briefing highlights results of national patient research indicating the need to improve medication adherence, access to medication and enrollment of women in clinical trials, policy recommendations
COSTA MESA, Calif., Feb.
Cholesterol-lowering statin drugs have been linked to various side effects.
- a study of the individuals in a group of people within a specific context and their relationships.
- In rhetoric, the description of any one's personal appearance.